Bleeding from self-administration of phenindione: a detailed case study.
A young woman presented with a 2 year history of a severe bleeding disorder and marked deficiencies in all four vitamin-K-dependent factors. Metabolic studies with tracer doses of tritium-labelled vitamin K1 suggested that the patient might be taking an oral anticoagulant; and subsequently her plasma was found to contain a substance identical to phenindione in its spectrophotometric and chromatographic properties. The half-disappearance times of factors II, IX, X were measured after the administration of a concentrate of these factors and were found to conform with published figures. The concentrate controlled the patient's excessive bruising and prolonged skin and gingival bleeding. It would therefore seem that factor VII may not be essential in reversal of the bleeding disorder induced by anticoagulant overdose.
D000328:Adult; D000740:Anemia / Q000150:complications; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000209:etiology*; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D002849:Chromatography, Gas; D002855:Chromatography, Thin Layer; D048909:Diabetes Complications; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000097:blood; D006396:Hematemesis / Q000150:complications; D006417:Hematuria / Q000150:complications; D006801:Humans; D008595:Menorrhagia / Q000150:complications; D010630:Phenindione / Q000097:blood; D012651:Self Medication; D013057:Spectrum Analysis; D019966:Substance-Related Disorders; D014812:Vitamin K / Q000097:blood / Q000627:therapeutic use / Q000652:urine; D014859:Warfarin / Q000097:blood
D001779:Blood Coagulation Factors; D014812:Vitamin K; D010630:Phenindione; D014859:Warfarin; D005954:Glucosephosphate Dehydrogenase